This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The Population Assessment of Tobacco and Health (PATH) Study is a rich data source for researchers. To further the understanding and use of the PATH Study data files, Westat’s Katy Edwards, PhD, and Rui Jiao, MS will be leading the PATH Study Data User Workshop in-person on July 29-30, 2024 and virtually on August 12-13, 2024. Edwards, a Senior Research Associate in the Behavioral Health and Health Policy practice, has been working on the PATH Study for 7 years and brings her tobacco research expertise. Jiao, a Principal Statistical Associate, brings expertise on the sample design, weighting, and response prediction of PATH Study data to this workshop.
The workshop will be a combination of lecture, discussion, and exercises, and will use hands-on examples to help attendees better understand the PATH Study sample design and weighting. They will learn how to conduct longitudinal analyses to estimate change over time, as well as pseudo-cross-sectional analyses to estimate prevalence.
The free course is designed for academic faculty and research professionals, as well as graduate students interested in tobacco regulatory science and/or prevention/translation research.
Applications are due by May 31, 2024. Enrollment is limited and admission to the workshop is competitive. The workshop is available to attend either in-person in Ann Arbor, Michigan from July 29-30, 2024, or via Zoom on August 12-13, 2024. For more information on the workshop, please visit: The Population Assessment of Tobacco and Health (PATH) Study Data User Workshop.
The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The PATH Study is a household-based, nationally representative, longitudinal cohort study of approximately 46,000 adults and youth (ages 12-17) in the U.S. The Study was launched in 2011 to inform the FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act that was signed into law in 2009.